# Boston Scientific to acquire Intera Oncology

Boston Scientific agreed to acquire Intera Oncology, a medical device company that provides the Intera 3000 Hepatic Artery Infusion Pump and floxuridine for treating liver tumors. The acquisition expands Boston Scientific's interventional oncology offerings.

- Type: Acquisition
- Announced: 2024-11-25
- Where: Marlborough, Massachusetts, United States
- Value: $664.0M
- Status: announced
- Products: hepatic artery infusion pump, floxuridine
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Boston Scientific](https://endata.com/companies/15966.md) (acquirer)
- [Intera Oncology](https://endata.com/companies/81279.md) (target)
- [Bolt Medical](https://endata.com/companies/82182.md) (target)

## Sources

- [news.bostonscientific.com](https://news.bostonscientific.com/2024-11-25-Boston-Scientific-Announces-Agreement-to-Acquire-Intera-Oncology-R-Inc), 2024-11-25: "Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Intera Oncology® Inc."
- [news.bostonscientific.com](https://news.bostonscientific.com/2025-01-08-Boston-Scientific-Announces-Agreement-to-Acquire-Bolt-Medical,-Inc), 2025-01-08: "Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for the treatment of coronary and peripheral artery disease."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.